UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 134

Sortiert nach

Oncogenically active MYD88 mutations in human lymphoma

Nature (London), 2011-02, Vol.470 (7332), p.115-119

2011

Volltextzugriff (PDF)

Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab

Journal of clinical oncology, 2011-01, Vol.29 (2), p.200-207

2011

Volltextzugriff (PDF)

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

The New England journal of medicine, 2010-03, Vol.362 (10), p.875-885

2010

Volltextzugriff (PDF)

A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

Clinical cancer research, 2009-09, Vol.15 (17), p.5494-5502

2009

Volltextzugriff (PDF)

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016

Journal of clinical oncology, 2018-03, Vol.36 (7), p.697-703

2018

Volltextzugriff (PDF)

Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP

Journal of clinical oncology, 2013-12, Vol.31 (36), p.4520-4528

2013

Volltextzugriff (PDF)

New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies

Journal of clinical oncology, 2017-05, Vol.35 (15), p.1668-1677

2017

Volltextzugriff (PDF)

Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016

Journal of clinical oncology, 2013-01, Vol.31 (3), p.314

2013

Volltextzugriff (PDF)

Phase II Trial of CHOP Chemotherapy Followed by Tositumomab/Iodine I-131 Tositumomab for Previously Untreated Follicular Non-Hodgkin's Lymphoma: Five-Year Follow-Up of Southwest Oncology Group Protocol S9911

Journal of clinical oncology, 2006-09, Vol.24 (25), p.4143-4149

2006

Volltextzugriff (PDF)

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling

The American journal of surgical pathology, 2015-10, Vol.39 (10), p.1322-1330

2015

Volltextzugriff (PDF)

BCL2 Predicts Survival in Germinal Center B-cell―like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab

Clinical cancer research, 2011-12, Vol.17 (24), p.7785-7795

2011

Volltextzugriff (PDF)

Molecular Diagnosis of Burkitt's Lymphoma

The New England journal of medicine, 2006-06, Vol.354 (23), p.2431-2442

2006

Volltextzugriff (PDF)

Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations

American journal of clinical pathology, 2004-04, Vol.121 (4), p.464-472

2004

Volltextzugriff (PDF)

Accurate Classification of Diffuse Large B-Cell Lymphoma into Germinal Center and Activated B-Cell Subtypes Using a Nuclease Protection Assay on Formalin-Fixed, Paraffin-Embedded Tissues

Clinical cancer research, 2011-06, Vol.17 (11), p.3727-3732

2011

Volltextzugriff (PDF)

Mutation and Genomic Deletion Status of ataxia telangiectasia mutated (ATM) and p53 Confer Specific Gene Expression Profiles in Mantle Cell Lymphoma

Proceedings of the National Academy of Sciences - PNAS, 2006-02, Vol.103 (7), p.2352-2357

2006

Volltextzugriff (PDF)

Multiplex high-throughput gene mutation analysis in acute myeloid leukemia

Human pathology, 2012-12, Vol.43 (12), p.2167-2176

2012

Volltextzugriff (PDF)

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131 I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016

Journal of clinical oncology, 2018-03, Vol.36 (7), p.697-703

2018

Volltextzugriff (PDF)

BCL2 Translocation Defines a Unique Tumor Subset within the Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

The American journal of pathology, 2004-07, Vol.165 (1), p.159-166

2004

Volltextzugriff (PDF)

Immunophenotypic Variations of Burkitt Lymphoma

American journal of clinical pathology, 2010-07, Vol.134 (1), p.127-138

2010

Volltextzugriff (PDF)

Hypothesis: Sarcoidosis is a STAT1-mediated disease

Clinical immunology (Orlando, Fla.), 2009-08, Vol.132 (2), p.174-183

2009

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Aktive Filter

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Englisch
(134)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Humans
(73)
Science & Technology
(61)
Life Sciences & Biomedicine
(57)
Biological And Medical Sciences
(47)
Medical Sciences
(46)
Hematologic And Hematopoietic Diseases
(39)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(37)
Male
(37)
Middle Aged
(34)
Female
(33)
Adult
(28)
Pathology
(26)
Aged
(22)
Oncology
(18)
Immunohistochemistry
(16)
Aged, 80 And Over
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Gene Expression Profiling
(14)
Prognosis
(14)
Lymphoma, Large B-Cell, Diffuse - Genetics
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Oncogenically active MYD88 mutations in human lymphoma

Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP

New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies

Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016

Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms

Phase II Trial of CHOP Chemotherapy Followed by Tositumomab/Iodine I-131 Tositumomab for Previously Untreated Follicular Non-Hodgkin's Lymphoma: Five-Year Follow-Up of Southwest Oncology Group Protocol S9911

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling

BCL2 Predicts Survival in Germinal Center B-cell―like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab

Molecular Diagnosis of Burkitt's Lymphoma

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma

Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations

Accurate Classification of Diffuse Large B-Cell Lymphoma into Germinal Center and Activated B-Cell Subtypes Using a Nuclease Protection Assay on Formalin-Fixed, Paraffin-Embedded Tissues

Mutation and Genomic Deletion Status of ataxia telangiectasia mutated (ATM) and p53 Confer Specific Gene Expression Profiles in Mantle Cell Lymphoma

Multiplex high-throughput gene mutation analysis in acute myeloid leukemia

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131 I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016

BCL2 Translocation Defines a Unique Tumor Subset within the Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

Immunophenotypic Variations of Burkitt Lymphoma

Hypothesis: Sarcoidosis is a STAT1-mediated disease

Aktive Filter

Suchergebnisse filtern